Researchers track cell development using CRISPR

crispr

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Alexander Schier simply wanted to make sure he destroyed a gene in zebrafish embryos, so he turned to the genome-editing system known as CRISPR. But Schier, a developmental biologist at Harvard University, ended up doing more than knocking out a gene. He and colleagues devised a new way to mark and trace cells in a developing animal. In its first test, described in Science, the researchers used CRISPR-induced mutations to reveal a surprise: Many tissues and organs in adult zebrafish form from just a few embryonic cells.

Schier and his colleagues took advantage of what Harvard geneticist George Church calls CRISPR’s “genome vandalism.” In normal CRISPR editing, a so-called guide RNA precisely targets the enzyme Cas9 to a particular site in the genome so that it can break the double-stranded DNA there. In one of CRISPR’s original uses, a template DNA tells the cell’s machinery how to repair the double-stranded break, allowing edits as precise as the changing of a single nucleotide.

Read full, original post: Genome editor CRISPR helps trace growth of embryos – and maybe cancer next

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.